Some studies have shown that leptin has oncogenic activity via activation of the PI3K/Akt pathway and signal transducer and activator of transcription (STAT) 3 and STAT5 in tumor cells, whereas adiponectin inhibits leptin-associated pathways [25,30]. This evidence concerns the gene LEP and neoplasm.